 | 普视康成立于2021年，是一家专注于眼健康和眼科领域高新耗材技术的创新型企业。我们的核心产品是国产领扣型人工角膜，为角膜盲患者带来了重见光明的希望。同时，我们不断探索和引入更多高科技含量的眼科产品，提供丰富的治疗选择和方案。 自成立以来，我们与眼科专家学者紧密合作，共同致力于改善眼部疾病的诊断和治疗方法，为更多人带来健康的视力。通过持续的技术创新和发展，我们努力扩大康复前景，为患者创造更广阔的治疗可能性。普视康将持续努力，提供先进可靠的眼科产品，助力实现更多人的眼部健康。 Pushikang was established in 2021 as an innovative company focused on eye health and advanced consumable technologies in the field of ophthalmology. Our core product is a domestically produced lace-up artificial cornea, which brings hope of restored vision to corneal blindness patients. Additionally, we continuously explore and introduce high-tech ophthalmic products, offering a wide range of treatment options and solutions. Since our inception, we have closely collaborated with ophthalmic experts and scholars to improve the diagnosis and treatment methods for ocular diseases, aiming to bring healthy vision to more people. Through continuous technological innovation and development, we strive to expand the prospects of rehabilitation and create broader treatment possibilities for patients. Pusikang remains committed to providing advanced and reliable ophthalmic products, contributing to the ocular health of a greater number of individuals. |
领扣型人工角膜是参照国际上应用得最广泛的人工角膜——美国波士顿 I 型人工角膜设计的一款人工角膜。美国波士顿（Boston）人工角膜在1992年获得美国食品和药品监督管理局批准，在全世界多个国家应用，是现今为止最成熟的人工角膜。领扣型人工角膜是结合我国患者眼部解剖结构设计的一款人工角膜，包括镜柱、后板和卡圈三个部分，其中光学镜柱的曲面粗糙度、光学分辨率和光学偏心、最薄厚度等主要指标优于美国人工角膜标准，处于国际领先水平。 领扣型人工角膜手术适应症: |  |
